Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Cardima (US) makes appointment:

This article was originally published in Clinica

Executive Summary

Cardima (Fremont, California), a developer of systems for the minimally invasive treatment of atrial fibrillation, has appointed Daniel Cher to the newly-created role of medical director. The company hopes that Dr Cher, who most recently served as managing scientist at consultancy Exponent Failure Analysis, will strengthen Cardima's presence in regulatory and clinical activities worldwide. At Exponent, Dr Cher was responsible for managing scientific consultation projects in the areas of clinical trial design and analysis for several large and small device companies, including obtaining the PMA approval for Essure, the female sterilisation device manufactured by Conceptus.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065139

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel